These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8052342)
21. Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients. Johnston PS; Coniff RF; Hoogwerf BJ; Santiago JV; Pi-Sunyer FX; Krol A Diabetes Care; 1994 Jan; 17(1):20-9. PubMed ID: 8112185 [TBL] [Abstract][Full Text] [Related]
22. Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. Gupta A; Gupta R; Lal B J Assoc Physicians India; 2001 Nov; 49():1057-61. PubMed ID: 11868855 [TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes. Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032 [TBL] [Abstract][Full Text] [Related]
24. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [TBL] [Abstract][Full Text] [Related]
25. The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus. Osonoi T; Saito M; Mochizuki K; Fukaya N; Muramatsu T; Inoue S; Fuchigami M; Goda T Metabolism; 2010 Dec; 59(12):1816-22. PubMed ID: 20667563 [TBL] [Abstract][Full Text] [Related]
26. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients. Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675 [TBL] [Abstract][Full Text] [Related]
28. The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes. Chiasson JL; Naditch L; Diabetes Care; 2001 Jun; 24(6):989-94. PubMed ID: 11375358 [TBL] [Abstract][Full Text] [Related]
29. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes. Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560 [TBL] [Abstract][Full Text] [Related]
30. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients. Kumar S; Prange A; Schulze J; Lettis S; Barnett AH Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807 [TBL] [Abstract][Full Text] [Related]
31. Glucose turnover and gluconeogenesis during pregnancy in women with and without insulin-dependent diabetes mellitus. Chiasson JL; el Achkar GG; Ducros F; Bourque J; Maheux P Clin Invest Med; 1997 Jun; 20(3):140-51. PubMed ID: 9189645 [TBL] [Abstract][Full Text] [Related]
32. Alpha glucosidase inhibition in the treatment of non-insulin-dependent diabetes mellitus. Scott AR; Tattersall RB Diabet Med; 1988 Jan; 5(1):42-6. PubMed ID: 2964327 [TBL] [Abstract][Full Text] [Related]
33. Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition. Johnston PS; Feig PU; Coniff RF; Krol A; Kelley DE; Mooradian AD Diabetes Care; 1998 Mar; 21(3):416-22. PubMed ID: 9540025 [TBL] [Abstract][Full Text] [Related]
34. [Inhibitors of alpha-glucosidase]. Toeller M Journ Annu Diabetol Hotel Dieu; 1991; ():203-12. PubMed ID: 1886331 [No Abstract] [Full Text] [Related]
35. Reduction of postprandial blood glucose by the alpha-glucosidase inhibitor Miglitol (BAY m 1099) in type II diabetes. Heinz G; Komjati M; Korn A; Waldhäusl W Eur J Clin Pharmacol; 1989; 37(1):33-6. PubMed ID: 2687007 [TBL] [Abstract][Full Text] [Related]
36. Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients. Pagano G; Marena S; Corgiat-Mansin L; Cravero F; Giorda C; Bozza M; Rossi CM Diabete Metab; 1995 Jun; 21(3):162-7. PubMed ID: 7556806 [TBL] [Abstract][Full Text] [Related]
37. Effect of miglitol administration to non-insulin-dependent diabetic rats. Tormo MA; Ropero MF; Nieto M; Martinez IM; Campillo JE Gen Pharmacol; 1998 Jan; 30(1):125-9. PubMed ID: 9457493 [TBL] [Abstract][Full Text] [Related]
38. Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus. Scott LJ; Spencer CM Drugs; 2000 Mar; 59(3):521-49. PubMed ID: 10776834 [TBL] [Abstract][Full Text] [Related]
39. Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics. Standl E; Schernthaner G; Rybka J; Hanefeld M; Raptis SA; Naditch L Diabetes Res Clin Pract; 2001 Mar; 51(3):205-13. PubMed ID: 11269893 [TBL] [Abstract][Full Text] [Related]
40. [Usefulness of miglitol in patients with diabetes mellitus type 2 and insufficient control of the blood glucose]. de Luis Román DA; del Pozo García E; Aller R; Romero Bobillo E; Conde Valentín R Rev Clin Esp; 2004 Jan; 204(1):32-4. PubMed ID: 14746760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]